Products
Our products
Learn more about our product portfolio and how we’re prioritizing vaccines and specialty medicines to get ahead of disease together.
Scroll to explore
Our product areas
Our portfolio spans three product areas: vaccines, specialty and general medicines. We’re prioritizing R&D investment in vaccines and specialty medicines, which we expect to grow to around three quarters of our business by 2026.